These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 1548827

  • 1. Recombinant human DNase inhalation in normal subjects and patients with cystic fibrosis. A phase 1 study.
    Aitken ML, Burke W, McDonald G, Shak S, Montgomery AB, Smith A.
    JAMA; 1992 Apr 08; 267(14):1947-51. PubMed ID: 1548827
    [Abstract] [Full Text] [Related]

  • 2. Safety of repeated intermittent courses of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis.
    Eisenberg JD, Aitken ML, Dorkin HL, Harwood IR, Ramsey BW, Schidlow DV, Wilmott RW, Wohl ME, Fuchs HJ, Christiansen DH, Smith AL.
    J Pediatr; 1997 Jul 08; 131(1 Pt 1):118-24. PubMed ID: 9255202
    [Abstract] [Full Text] [Related]

  • 3. Medium term treatment of stable stage cystic fibrosis with recombinant human DNase I.
    Shah PL, Scott SF, Fuchs HJ, Geddes DM, Hodson ME.
    Thorax; 1995 Apr 08; 50(4):333-8. PubMed ID: 7785003
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis.
    Ramsey BW, Astley SJ, Aitken ML, Burke W, Colin AA, Dorkin HL, Eisenberg JD, Gibson RL, Harwood IR, Schidlow DV.
    Am Rev Respir Dis; 1993 Jul 08; 148(1):145-51. PubMed ID: 8317790
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Bolus inhalation of rhDNase with the AERx system in subjects with cystic fibrosis.
    Geller D, Thipphawong J, Otulana B, Caplan D, Ericson D, Milgram L, Okikawa J, Quan J, Bowman CM.
    J Aerosol Med; 2003 Jul 08; 16(2):175-82. PubMed ID: 12823911
    [Abstract] [Full Text] [Related]

  • 8. Multicenter, open-label study of recombinant human DNase in cystic fibrosis patients with moderate lung disease. DNase International Study Group.
    Harms HK, Matouk E, Tournier G, von der Hardt H, Weller PH, Romano L, Heijerman HG, FitzGerald MX, Richard D, Strandvik B, Kolbe J, Kraemer R, Michalsen H.
    Pediatr Pulmonol; 1998 Sep 08; 26(3):155-61. PubMed ID: 9773909
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of hypertonic saline and alternate-day or daily recombinant human deoxyribonuclease in children with cystic fibrosis: a randomised trial.
    Suri R, Metcalfe C, Lees B, Grieve R, Flather M, Normand C, Thompson S, Bush A, Wallis C.
    Lancet; 2001 Oct 20; 358(9290):1316-21. PubMed ID: 11684212
    [Abstract] [Full Text] [Related]

  • 18. [Multicenter study of rhDNase in cystic fibrosis with severe pulmonary involvement].
    Hodson M.
    Arch Pediatr; 1995 Jul 20; 2(7):679-81. PubMed ID: 7663660
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.